MTHFR (C677T)基因多态性与脑梗死风险因素及预后的相关性分析
Correlation Analysis between MTHFR (C677T) Gene Polymorphism and Risk Factors and Prognosis of Cerebral Infarction
DOI: 10.12677/acm.2024.143936, PDF,    科研立项经费支持
作者: 谭文茜, 孙博谦*:北华大学附属医院神经内科,吉林 吉林;王 莉:定西市人民医院神经内科,甘肃 定西
关键词: MTHFR (C677T)基因多态性脑梗死同型半胱氨酸MTHFR (C677T) Gene Polymorphism Cerebral Infarction Homocysteine
摘要: 目的:探究亚甲基四氢叶酸还原酶MTHFR (C677T)基因多态性与脑梗死风险因素及预后相关性,为脑梗死的二级预防及治疗提供理论支持。方法:选取2021年4月至2021年8月期间就诊于北华大学附属医院神经内科首发症状性脑梗死患者50例(男性39例,女性患者11例),平均年龄(66.6 ± 10.54)岁。以C677T基因型进行分组:野生型组(CC)、突变组(CT TT),收集患者一般资料、个人史、既往史、量表分数(NIHSS评分、Barthel指数)及症状复发。结果:1) 单因素分析结果显示在MTHFR (C677T)基因年龄、症状首发年龄、冠心病病史、糖尿病病史、吸烟史、饮酒史比较,差异无统计学意义(P > 0.05);2) 单因素分析结果显示MTHFR (C677T)基因多态性与脑梗死患者的性别、高血压、入院时严重程度、症状复发具有相关性,差异有统计学意义(P < 0.05);3) 在多变量分析结果显示MTHFR (C677T)是脑梗死复发的独立危险因素,CT TT基因型复发的概率是CC基因型的9.25倍,即MTHFR (C677T)基因突变时,脑梗死的复发率增高。结论:MTHFR (C677T)基因多态性与脑梗死的发生具有相关性,是脑梗死发生的独立危险因素。
Abstract: Objective: To explore the correlation between MTHFR (C677T) gene polymorphism and risk factors and prognosis of cerebral infarction, and to provide theoretical support for secondary prevention and treatment of cerebral infarction. Methods: A total of 50 patients (39 males and 11 females) with an average age of (66.6 ± 10.54) were enrolled in the Department of Neurology, Affiliated Hospital of North China University from April to August 2021. Patients were divided into wild type group (CC) and mutant group (CT TT) with C677T genotype. General information, personal history, past history, scale score (NIHSS score, Barthel index) and symptom recurrence were collected. Results: 1) Univariate analysis showed no significant difference in MTHFR (C677T) gene age, age of first symptom onset, history of coronary heart disease, history of diabetes, smoking history and drinking history (P > 0.05). 2) The results of univariate analysis showed that MTHFR (C677T) gene polymorphism was associated with gender, hypertension, severity at admission and symptom recurrence of cerebral infarction patients, with statistical significance (P < 0.05). 3) Multivariate analysis showed that MTHFR (C677T) was an independent risk factor for cerebral infarction recurrence, and the recurrence probability of CT TT genotype was 9.25 times that of CC genotype, that is, the recurrence rate of cerebral infarction increased when MTHFR (C677T) gene was mutated. Conclusion: MTHFR (C677T) gene polymorphism is associated with the occurrence of cerebral infarction and is an independent risk factor for cerebral infarction.
文章引用:谭文茜, 王莉, 孙博谦. MTHFR (C677T)基因多态性与脑梗死风险因素及预后的相关性分析[J]. 临床医学进展, 2024, 14(3): 2005-2012. https://doi.org/10.12677/acm.2024.143936

参考文献

[1] Fan, H., Yang, S., Li, Y., et al. (2018) Assessment of Homocysteine as a Diagnostic and Early Prognostic Biomarker for Patients with Acute Lacunar Infarction. European Neurology, 79, 54-62. [Google Scholar] [CrossRef] [PubMed]
[2] Fu, H.J., Zhao, L.B., Xue, J.J., et al. (2015) Elevated Serum Homocysteine (Hcy) Levels May Contribute to the Pathogenesis of Cere-Bral Infarction. Journal of Molecular Neuroscience, 56, 553-561. [Google Scholar] [CrossRef] [PubMed]
[3] 朱嫦琳, 陈斌鸿, 薛雄燕, 等. 脑梗死患者MTHFR基因C677T多态性与同型半胱氨酸水平的相关性[J]. 实用医学杂志, 2018, 34(23): 3990-3993.
[4] Li, P. and Qin, C. (2013) Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphisms and Susceptibility to Ischemic Stroke: A Meta-Analysis. Gene, 10, 359-64. [Google Scholar] [CrossRef] [PubMed]
[5] Cui, T. (2016) MTHFR C677T Mutation Increased the Risk of Ischemic Stroke, Especially in Large-Artery Atherosclerosis in Adults: An Updated Meta-Analysis from 38 Researches. International Journal of Neuroscience, 126, 10-19. [Google Scholar] [CrossRef] [PubMed]
[6] 周浩, 魏守超, 赵兴军, 等. 5,10-亚甲基四氢叶酸还原酶基因多态性与脑梗死患者颈动脉粥样硬化的相关性研究[J]. 中国卒中杂志, 2017, 12(1): 23-28.
[7] 陈芳, 吕海东, 秦东香, 等. 中青年缺血性脑血管病与MTHFR基因多态性及血浆同型半胱氨酸的相关性[J]. 中华神经医学杂志, 2014, 13(5): 489-493.
[8] 施梦丽, 弓园芳, 陈淅泠. 同型半胱氨酸浓度及MTHFR基因多态性与缺血性脑卒中的相关性[J]. 中国实用神经疾病杂志, 2014, 17(17): 53-54.
[9] Rut Tenjacobs, L.C., Traylor, M., Adibsamii, P., et al. (2016) Association of MTHFR C677T Genotype with Ischemic Stroke Is Confined to Cerebral Small Vessel Disease Subtype. Stroke, 47, 646-651. [Google Scholar] [CrossRef
[10] 刘海艳, 魏秀娥, 荣良群, 等. MTHFR C677T基因多态性对干预Hhcy后脑梗死复发的影响[J]. 中国实用神经疾病杂志, 2018, 21(16): 1767-1771.
[11] Zhou, Bs., Bu, Gy., Li, M., et al. (2014) Tagging SNPs in the MTHFR Gene and Risk of Ischemic Stroke in a Chinese Population. International Journal of Molecular Sciences, 15, 8931-8940. [Google Scholar] [CrossRef] [PubMed]
[12] Ni, J., Liu, Y., Zhou, T., et al. (2018) Single Nucleotide Polymorphisms in Key One-Carbon Metabolism Genes and Their Association with Blood Folate and Homocysteine Levels in a Chinese Population in Yunnan. Genetic Testing and Molecular Biomarkers, 22, 193-198. [Google Scholar] [CrossRef] [PubMed]
[13] 庞国勋, 靳会欣, 刘洪涛. 脑卒中患者MTHFR基因多态性与同型半胱氨酸水平的关系研究[J]. 解放军医药杂志, 2018, 30(12): 98-100. [Google Scholar] [CrossRef
[14] Jadavji, N., Emmerson, J., Shanmugalingam, U., et al. (2018) A Genetic Deficiency in Folic Acid Metabolism Impairs Recovery after Ischemic Stroke. Experimental Neurology, 309, 14-22. [Google Scholar] [CrossRef] [PubMed]
[15] Lehotsky, J., Petras, M., Kovalska, M., et al. (2015) Mechanisms Involved in the Ischemic Tolerance in Brain: Effect of the Homocysteine. Cellular and Molecular Neurobiology, 35, 7-15. [Google Scholar] [CrossRef] [PubMed]
[16] 张蕾, 冯晓俊, 秦立婷, 等. 脑卒中患者MTHFR基因多态性与H型高血压的相关性[J]. 中国临床保健杂志, 2021, 24(4): 502-506. [Google Scholar] [CrossRef
[17] Abdelaziz, T.A. and Mohamed, R.H. (2017) Influence of MTHFR (C677T) Gene Polymorphism in the Development of Cardiovascular Disease in Egyptian Patients with Rheumatoid Arthritis. Gene, 610, 127-132. [Google Scholar] [CrossRef] [PubMed]
[18] De Gracia Hahn, D., Duret, A. and Mann, J.P. (2019) An AGTR1 Variant Worsens Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome. The American Journal of Gastroenterology, 114, 556-559. [Google Scholar] [CrossRef] [PubMed]
[19] Sorokin, V., Vickneson, K., Kofidis, T., et al. (2020) Role of Vascular Smooth Muscle Cell Plasticity and Interactions in Vessel Wall Inflammation. Frontiers in Immunology, 11, 599415. [Google Scholar] [CrossRef] [PubMed]
[20] Kimura, S., Noguchi, H., Nanbu, U., et al. (2018) Relationship between CCL22 Expression by Vascular Smooth Muscle Cells and Macrophage Histamine Receptors in Atherosclerosis. Journal of Atherosclerosis and Thrombosis, 25, 1240-1254. [Google Scholar] [CrossRef] [PubMed]
[21] Hand, B., Page, S.J. and White, S. (2014) Stroke Survivors Scoring Zero on the NIH Stroke Scale Score Still Exhibit Significant Motor Impairment and Functional Limitation. Stroke Research and Treatment, 2014, Article ID 462681. [Google Scholar] [CrossRef] [PubMed]
[22] Thorén, M., Azevedo, E., Dawson, J., et al. (2017) Predictors for Cerebral Edema in Acute Ischemic Stroke Treated with Intravenous Thrombolysis. Stroke, 48, 2464-2471. [Google Scholar] [CrossRef
[23] 焦建华, 马瑞雪, 谷宏宏, 等. 脑卒中患者CCR2和CRP水平与卒中相关性肺炎严重程度的关系及临床意义[J]. 国际检验医学杂志, 2024, 45(2): 184-187 193.
[24] 赵青梅, 石庆丽. 急性脑梗死患者阿替普酶静脉溶栓治疗后预后不良的影响因素分析[J]. 中国临床医生杂志, 2024, 52(1): 55-58.